Literature DB >> 13508913

Treatment of psychiatric disorders with triiodothyronine.

F F FLACH, C I CELIAN, R W RAWSON.   

Abstract

Entities:  

Keywords:  MENTAL DISORDERS/therapy; TRIIODOTHYRONINE/therapeutic use

Mesh：

Substances：

Year:  1958        PMID： 13508913     DOI： 10.1176/ajp.114.9.841

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  6 in total

1.  The etiology of schizophrenia. A review.

Authors:  A J FERREIRA
Journal:  Calif Med       Date:  1961-06

2.  Response to triiodothyronine and dextroamphetamine: a study of preschool schizophrenic children.

Authors:  M Campbell; B Fish; R David; T Shapiro; P Collins; C Koh
Journal:  J Autism Child Schizophr       Date:  1972 Oct-Dec

Review 3.  Refractory depression: treatment strategies, with particular reference to the thyroid axis.

Authors:  R T Joffe
Journal:  J Psychiatry Neurosci       Date:  1997-11       Impact factor: 6.186

4.  The combination of triiodothyronine (T3) and sertraline is not superior to sertraline monotherapy in the treatment of major depressive disorder.

Authors:  Steven J Garlow; Boadie W Dunlop; Philip T Ninan; Charles B Nemeroff
Journal:  J Psychiatr Res       Date:  2012-09-07       Impact factor: 4.791

Review 5.  Mechanisms of antidepressant resistance.

Authors:  Wissam El-Hage; Samuel Leman; Vincent Camus; Catherine Belzung
Journal:  Front Pharmacol       Date:  2013-11-22       Impact factor: 5.810

Review 6.  Role of thyroid hormone therapy in depressive disorders.

Authors:  M Bauer; P C Whybrow
Journal:  J Endocrinol Invest       Date:  2021-06-15       Impact factor: 4.256
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.